Welcome and Introduction
2011-05-18 - English

Patient: Doctor Relationship - FAQ
2011-05-18 - English

Patient: Doctor Relationship - Perceptions
2011-05-18 - English

Patient Support Groups
2011-05-18 - English

Introductory Debate: Morphology is Dead, Long Live Morphology
2011-05-19 - English

Molecular Analysis as a Diagnostic Tool
2011-05-19 - English

1. To learn the range of tools currently used to characterize the molecular basis of MDS.
2. To understand the information that may be gained from these tools.
3. To understand potential obstacles preventing adoption of these tools in the routine diagnostic workup of patients with MDS.

Recent Advances in Cytogenetic Risk Scoring in MDS
2011-05-19 - English

- know the prognostic relevance of cytogenetic findings in MDS
- know cytogentic prognostic subgroups
- know the background and the shape of our new cytogenetic scoring system for MDS
- to estimate the progress of prognostic accuracy of cytogenetics in MDS
- get some impression of future developments in this field

New Prognostic Scores and Q&A
2011-05-19 - English

Cellular identity, molecular determinants and clinical surveillance of MDS stem cells and Q&A
2011-05-19 - English

Hematopoietic stem cells and leukemia in the niche and Q&A
2011-05-19 - English

Molecular pathogenesis of the 5q- syndrome and Q&A
2011-05-19 - English

5Q and Q&A
2011-05-19 - English

Mouse Models of MDS and Q&A
2011-05-19 - English

Vaccine Therapy for Myeloid Malignancy and Q&A
2011-05-19 - English

New Mutations in MDS and Q&A
2011-05-20 - English

Gene deletions and mutations in chronic myelomonocytic leukaemia and Q&A
2011-05-20 - English

Juvenile myelomonocytic leukemia: How many entities? and Q&A
2011-05-20 - English

Debate: Iron chelation therapy, as recommended in National MDS Management Guidelines, is an established standard of care ' - contrarian position'
2011-05-20 - English

Thrombomimetic agents in myelodysplastic syndromes and Q&A
2011-05-20 - English

Guidelines for immunosuppression in MDS
2011-05-20 - English

Optimising combination strategies and Q&A
2011-05-20 - English

Conditioning regimen for allogeneic stem cell transplantation in MDS and Q&A
2011-05-21 - English

- Different intensities of a conditioning regimen
- Different outcomes according to intensity
- Availability of new drugs incorporated within a conditioning regimen

Debate: Transfusion versus Transplant (Including Indications and Timing)
2011-05-21 - English

Nucleoside Analogues and Q&A
2011-05-21 - English

The identification of novel somatic mutations in MDS by whole exome sequencing
2011-05-21 - English

ASXL1 is frequently mutated and associated with a negative prognosis in MDS
2011-05-21 - English